ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 312 filers reported holding ROYALTY PHARMA PLC in Q3 2023. The put-call ratio across all filers is 0.16 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $6,151,362 | +428.0% | 226,653 | +498.0% | 0.02% | +500.0% |
Q2 2023 | $1,165,015 | -52.7% | 37,899 | -44.6% | 0.00% | -57.1% |
Q1 2023 | $2,464,884 | -2.9% | 68,412 | +6.5% | 0.01% | -12.5% |
Q4 2022 | $2,538,132 | +25.1% | 64,224 | +27.2% | 0.01% | +33.3% |
Q3 2022 | $2,029,000 | +88.4% | 50,487 | +97.0% | 0.01% | +100.0% |
Q2 2022 | $1,077,000 | +48.6% | 25,623 | +37.8% | 0.00% | +50.0% |
Q1 2022 | $725,000 | +1088.5% | 18,600 | +1228.6% | 0.00% | – |
Q1 2021 | $61,000 | -97.0% | 1,400 | -96.6% | 0.00% | -100.0% |
Q4 2020 | $2,042,000 | – | 40,800 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SIGULER GUFF ADVISERS, LLC | 6,761,970 | $244,378,000 | 79.54% |
Vantage Consulting Group Inc | 7,862,542 | $284,152,000 | 60.85% |
Memorial Sloan Kettering Cancer Center | 2,680,644 | $96,878,000 | 60.36% |
Indie Asset Partners, LLC | 701,323 | $25,346,000 | 20.53% |
HARVARD MANAGEMENT CO INC | 7,142,856 | $258,143,000 | 15.13% |
Bleichroeder LP | 1,115,980 | $40,332,000 | 6.55% |
Overbrook Management Corp | 785,132 | $28,375,000 | 6.16% |
Geo Capital Gestora de Recursos Ltd | 194,305 | $7,022,000 | 3.21% |
Brown University | 621,759 | $22,470,000 | 3.05% |
Graypoint LLC | 610,584 | $22,067,000 | 2.71% |